Verona Pharma (VRP)

Company name:Verona Pharma Plc
EPIC:VRPTrading Currency:GBX
Market Sector:AIMPISIN:GB00BYW2KH80
Market Segment:ASX1Share Type:DE
WWW Address: 5P
 Price Price Change [%] Bid Offer Open High Low Volume
 55.00 0.0 [0.00] 45.00 65.00 - - - -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 227.85 414.28 0.05 -18.90 - - - 98.50 - 50.00

Verona Pharma Key Figures

(at previous day's close)
Market Cap.227.85m
Shares In Issue414.28m
Prev. Close55.00
PE Ratio- 
Dividend Yield-%
EPS - basic-18.90p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-4.37p
Return On Equity (ROE)-31.56%
Operating Margin-%
PEG Factor- 
EPS Growth Rate19.23%
Dividends PS Growth Rate-%
Net Debt-8.46m
Gross Gearing15.25%
Quick Assets26.75m
Net Working Capital16.52m
Intangibles / Fixed Assets5.42%
Turnover PS-p
Pre-Tax Profit PS-5.83p
Retained Profit PS-4.79p
Cash PS4.78p
Net Cash PS2.31p
Net Tangible Asset Value PS *14.57p
Net Asset Value PS15.19p
Spread20.00 (30.77%) 

Verona Pharma Balance Sheet


Share Price Performance

Sorry No Data Available

Share Price Chart (5 years)

Verona Pharma Historic Returns

Sorry No Data Available

Verona Pharma Key Management Ratios

Verona Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 2.77 
Tobin's Q Ratio (excl. intangibles)2.85 
Dividend Yield-%
Market-to-Book Ratio3.62 
Price-to-Pre-Tax Profit PS-9.44 
Price-to-Retained Profit PS-11.47 
Price-to-Cash Flow PS-12.58 
Price-to-Sales PS- 
Price-to-Net Tangible Asset Value PS3.77 
Price-to-Cash PS11.52 
Net Working Capital PS3.99 
Price Pct to Working Capital PS13.79%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Verona Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio1.72%
Debt-to-Equity Ratio0.02 
Debt-to-Equity Ratio (excl. Intgbl)0.02 
Debt-to-Equity Market Value0.00 
Net Gearing-11.39%
Net Gearing (excl. Intangibles)-11.80%
Gross Gearing15.25%
Gross Gearing (excl. Intangibles)15.80%
Gearing Under 1 Year13.77%
Gearing Under 1 Year (excl. Intgbl)14.26%
(Liquidity Ratios)
Net Working Capital to Total Assets22.25%
Current Ratio2.62 
Quick Ratio (Acid Test)2.62 
Liquidity Ratio1.93 
Cash & Equiv/Current Assets73.97%
(Solvency Ratios)
Enterprise Value209.17m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.05 
Total Debt/Sales- 
Total Debt/Pre-Tax Profit-0.47 
Total Debt11.33m
Total Debt/Net Current Assets0.69%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs7 
Beta (60-Mnth)Beta (36-Mnth)

Verona Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-37.69%
Return On Assets (ROA)-24.12%
Net Profit Margin-%
Assets Turnover- 
Return On Equity (ROE)-31.56%
Return On Investment (ROI)-27.38%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-%
(Asset Utilisation Multiples)
Shareholders Equity Turnover- 
Fixed Assets Turnover- 
Current Assets Turnover- 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales- 
Debt Collection Period-Days

Verona Pharma Dividends

Sorry No Data Available

Verona Pharma Fundamentals

 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
pre tax profit-8.93--5.97--25.20--24.13-m
attributable profit-7.42--5.02--20.53--19.86-m
retained profit-7.42--5.02--20.53--19.86-m
eps - basic (p)-0.73 -0.30 -23.40 -18.90 
eps - diluted (p)-0.73 -0.30 -23.40 -18.90 
dividends per share- - - - 

Verona Pharma Balance Sheet

 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
fixed assets fixed assets0.010.19%0.010.03%0.020.02%0.020.03%m
intangibles intangibles1.8124.50%2.325.02%2.412.67%2.583.47%m
fixed investments fixed investments--%--%49.7054.97%44.9260.49%m
current assets - other current assets - other--%--%--%--%m
stocks stocks--%--%--%--%m
debtors debtors2.0527.68%4.038.73%6.987.72%6.969.38%m
cash & securities cash & securities3.5247.63%39.7986.22%31.3134.63%19.7826.64%m
creditors - short creditors - short1.8124.50%10.8723.56%9.3310.32%10.2313.77%m
creditors - long creditors - long--%0.801.74%1.031.14%1.101.48%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves5.5975.50%34.4774.70%80.0588.54%62.9384.75%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Verona Pharma Cash Flow Statement

31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
Operating CF-6.35-5.59-20.70-18.11m
Pre-Financing CF-6.45-5.63-70.17-12.83m
Retained CF-6.4535.57-6.92-12.83m

Verona Pharma Brokers

Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Jefferies International LtdMarket Maker(MMF)Broker/DealerJEFFJEFFGB2X
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
ADVFN Advertorial
Your Recent History
Verona Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210725 21:21:32